Poster Presentation 14th Australian Peptide Conference 2022

Biosynthesis of the potent antitrypanosomal spoxazomicins A-C   (#133)

Chuan Huang 1 2 3 4 , Yuki Inahashi 5 , Taro Shiraishi 6 , Yoko Takahashi 5 , Tomohisa Kuzuyama 6 , Satoshi Ōmura 5 , Gregory L Challis 1 2 3 4
  1. Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia
  2. ARC Centre of Excellence for Innovations in Peptide and Protein Science, Monash University, Clayton, Victoria, Australia
  3. Warwick Integrative Synthetic Biology Centre, University of Warwick, Coventry, West Midlands, United Kingdom
  4. Department of Chemistry, University of Warwick, Coventry, West Midlands, United Kingdom
  5. Ōmura Satoshi Memorial Institute, Kitasato University, Minato-ku, Tokyo, Japan
  6. Laboratory of Cell Biotechnology, Biotechnology Research Center, The University of Tokyo, Bunkyo-ku, Tokyo, Japan
Publish consent withheld
  1. C. T. Walsh, Polyketide and Nonribosomal Peptide Antibiotics: Modularity and Versatility. Science. 303, 1805–1810 (2004).
  2. R. S. Roy, A. M. Gehring, J. C. Milne, P. J. Belshaw, C. T. Walsh, Thiazole and oxazole peptides: biosynthesis and molecular machinery. Nat. Prod. Rep. 16, 249–263 (1999).
  3. Y. Inahashi, A. Matsumoto, S. Ōmura, Y. Takahashi, Streptosporangium oxazolinicum sp. nov., a novel endophytic actinomycete producing new antitrypanosomal antibiotics, spoxazomicins. J. Antibiot. (Tokyo). 64, 297–302 (2011).
  4. Y. Inahashi, et al., Spoxazomicins A–C, novel antitrypanosomal alkaloids produced by an endophytic actinomycete, Streptosporangium oxazolinicum K07-0460T. J. Antibiot. (Tokyo). 64, 303–307 (2011).